Results 201 to 210 of about 2,908,953 (289)
Controllable Procedural Generation of Landscapes
Jia-Hong Liu +3 more
openaire +1 more source
Anatomy-Driven Aesthetic Design for Facial Contouring in Northeast Asian Females: A Conceptual Framework and Case Report. [PDF]
Kwon S.
europepmc +1 more source
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller +14 more
wiley +1 more source
Artificial intelligence in infection prevention and control education: toward intelligent, real-time clinical learning systems. [PDF]
Cao YL +10 more
europepmc +1 more source
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw +5 more
wiley +1 more source
Stent Undersizing and Malapposition: Mechanical Causes of Acute and Late Stent Failure. [PDF]
Toulgaridis F +6 more
europepmc +1 more source
ABSTRACT Objective To clarify the clinical relevance of dopamine transporter single‐photon emission computed tomography (DAT‐SPECT) abnormalities in amyotrophic lateral sclerosis (ALS), with a prespecified focus on sex‐stratified associations with disease progression and short‐term prognosis.
Tomoya Kawazoe +7 more
wiley +1 more source
Evidence on novel endovascular techniques in the ESO/EANS/ESMINT guideline on aneurysmal subarachnoid haemorrhage. [PDF]
Möhlenbruch MA, Bendszus M.
europepmc +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit +11 more
wiley +1 more source

